The EU-funded project REBECCA taps into the potential of Real-World Data to support clinical research and to improve existing clinical workflows.

It will combine clinical data with data obtained from multiple wearable, online behaviour and registry data to study the complex array of chronic comorbidities developed during breast cancer recovery. The data will be deployed within 7 clinical studies in 3 countries, involving over 650 individuals, and it will help shape future guidelines and practices for post-cancer treatment.

How will you benefit from REBECCA?                                                                 

Sign up to our newsletter

Sign up for our mailing list to receive occasional emails as we publish key project materials and commission new strands of work.

More impact of clinical research on breast cancer patients

Clinical and technological universities, industry leaders, public health experts, and patient associations will work together to shape guidelines and practices for post-cancer treatment. Best practices from the REBECCA studies will be disseminated to researchers, public health and regulatory bodies throughout Europe to facilitate wider adoption of RWD in clinical research.

REBECCA will provide an infrastructure for continued progress on the use of RWD beyond the project, facilitating the mass adoption of RWD as a valuable clinical research and patient management tool.

 

Find Out More

How we will do it

Our work packages are evolving, but include consideration and development of:

User requirements and co-creation
System design and integration
360º Patient monitoring using RWD
Causal inference and prediction using RWD
Clinical studies complemented by RWD
Improved patient outcomes through detailed monitoring
Improving research and clinical workflows using multi-source RWD
Dissemination and communication
Find out more

News

Find out about the latest REBECCA related news.

The Consortium

The project brings together 12 partners from 7 European countries. Clinical and technological universities, industry leaders, public health experts, and patient associations will work together to shape guidelines and practices for post-cancer treatment.

Find out more

“Cancer Survivorship – AI for Well-being”

Rebecca is a member of the “Cancer Survivorship – AI for Well-being” (CS_AIW) consortium, a collection of EU-funded projects that were launched in late 2020 under the banner of “Breaking Down Silos”. These projects share two fundamental principles. Firstly, they all aim to tackle critical issues surrounding mental health, well-being, depression, and patient support. Secondly, they embrace a participatory research philosophy, promoting a cohesive and collaborative approach to their endeavours.

 

Find Out More

Get in contact

If you have a question or feedback to give us, visit our contact page.